Patent details
EP2670405 Title: COMBINATIONS COMPRISING MACITENTAN FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME
Basic Information
- Publication number:
- EP2670405
- PCT Application Number:
- PCT/IB/2012/050513
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP127069250
- PCT Publication Number:
- WO/2012/104822
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATIONS COMPRISING MACITENTAN FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME
- French Title of Invention:
- COMBINAISONS CONTENANT DU MACITENTAN DESTINEES AU TRAITEMENT DU GLIOBLASTOMA MULTIFORME
- German Title of Invention:
- KOMBINATIONEN ENTHALTEND MACITENTAN ZUR BEHANDLUNG VON GLIOBLASTOMA MULTIFORME
- SPC Number:
Dates
- Filing date:
- 03/02/2012
- Grant date:
- 02/09/2015
- EP Publication Date:
- 02/09/2015
- PCT Publication Date:
- 09/08/2012
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 11/12/2013
- EP B1 Publication Date:
- 02/09/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 03/02/2016
- Expiration date:
- 03/02/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 03/02/2012
- Name:
- Actelion Pharmaceuticals Ltd.
- Address:
- Gewerbestrasse 16, 4123 Allschwil, Switzerland (CH)
Inventor
- Name:
- REGENASS Urs
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- 1/050494
- Priority Date:
- 04/02/2011
- Priority Country:
- International Bureau of WIPO (IB)
Classification
- Main IPC Class:
- A61K 31/337;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|